Medtronic plc — Director's Dealing 2017

Mar 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2017-03-01

Reporting Person: ARNOLD CRAIG (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-01	Ordinary Shares	M	15109	$27.38	Acquired	32913	Direct
2017-03-01	Ordinary Shares	F	6974	$82.07	Disposed	25939	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-01	Stock Option (Right to Buy)	$27.38	M	15109	Disposed	2017-07-02	Ordinary Shares (15109)	Direct

Footnotes

F1: This balance increased by 35 shares due to exempt transactions such as dividend reinvestment.

F2: In the Merger, Covidien options outstanding as of closing were converted into options to buy shares of New Medtronic. This option to purchase 15,109 New Medtronic ordinary shares for $27.38 per share was received in the Merger and represents the conversion of 10,521 Covidien ordinary shares for $39.32 per share, which were fully vested at the time of the Merger. The conversion ratio and exercise price was calculated according to the terms of the Transaction Agreement, which does not allow for options on fractional shares of New Medtronic. Other than as to the number of underlying shares and the exercise price, this New Medtronic stock option has the same terms and conditions as the original Covidien stock option.